Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Contrast Enhanced Ultrasound
Interventions: DRUG: Lumason
Sponsor: Milton S. Hershey Medical Center